; and (B) the cause of death for each such veteran. (7) The percentage of such veterans with combat experience or trauma (including military sexual trauma, traumatic brain injury, and post-traumatic stress). (8) Identification of medical facilities of the Department with high prescription and drug abuse treatment rates for patients being treated at those facilities. (9) A description of policies of the Department governing the prescribing of medications referred to in paragraph (3). (10) A description of efforts by the Secretary to electronically track, collect, and properly dispose of prescription opioids that are either unused, past the prescription date, or not in the possession of the properly prescribed patient. (11) A description of any patterns apparent to the Secretary based on the review. (12) Recommendations for further action that would improve the safety and well-being of veterans and reduce opioid overdose rates for veterans, especially concerning research regarding such veterans who had not filed for a opioid prescription in the three months before death by overdose. (c) Public availability Not later than 45 days after the completion of the review under subsection (a), the Secretary shall— (1) submit to Congress a report on the results of the review; (2) make such report publicly available; and (3) provide to the Committees on Veterans’ Affairs of the House of Representatives and the Senate a briefing on such review. (d) Definitions In this section: (1) The term black box warning means a warning displayed within a box in the prescribing information for drugs that have special problems, particularly ones that may lead to death or serious injury. (2) The term covered veteran means any veteran who received hospital care or medical services furnished by the Department of Veterans Affairs during the five-year period preceding the death of the veteran.